MENU
+Compare
MBOT
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$2.43
Change
+$0.35 (+16.83%)
Capitalization
18.57M

MBOT Microbot Medical Forecast, Technical & Fundamental Analysis

Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space... Show more

Industry: #Biotechnology
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MBOT with price predictions
Apr 23, 2025

Momentum Indicator for MBOT turns positive, indicating new upward trend

MBOT saw its Momentum Indicator move above the 0 level on April 09, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned positive. In of the 88 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for MBOT just turned positive on April 09, 2025. Looking at past instances where MBOT's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

MBOT moved above its 50-day moving average on April 10, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MBOT crossed bullishly above the 50-day moving average on April 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where MBOT advanced for three days, in of 213 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 101 cases where MBOT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MBOT moved out of overbought territory on April 21, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 49 cases where MBOT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MBOT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MBOT broke above its upper Bollinger Band on April 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MBOT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.525) is normal, around the industry mean (23.728). P/E Ratio (0.000) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (41.794).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MBOT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MBOT is expected to report earnings to fall 10.53% to -17 cents per share on November 29

Microbot Medical MBOT Stock Earnings Reports
Q3'24
Est.
$-0.17
Q4'24
Missed
by $0.01
Q2'24
Est.
$-0.17
Q1'24
Est.
$-0.17
Q4'23
Missed
by $0.02
The last earnings report on February 26 showed earnings per share of -18 cents, missing the estimate of -18 cents. With 3.44M shares outstanding, the current market capitalization sits at 18.57M.
A.I. Advisor
published General Information

General Information

a company, which specializes in the research, design, development and commercialization of micro-robotics assisted medical technologies

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
288 Grove Street
Phone
+1 781 875-3605
Employees
22
Web
https://microbotmedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRA2.000.13
+6.97%
Vera Bradley
CWAN22.300.39
+1.78%
Clearwater Analytics Holdings
HEPS2.870.05
+1.77%
D-Market Electronic Services & Trading
NEUP5.110.06
+1.19%
Neuphoria Therapeutics Inc
CQP59.160.27
+0.46%
Cheniere Energy Partners LP

MBOT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MBOT has been loosely correlated with RCEL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if MBOT jumps, then RCEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBOT
1D Price
Change %
MBOT100%
+1.46%
RCEL - MBOT
33%
Loosely correlated
+1.35%
CORBF - MBOT
33%
Loosely correlated
N/A
OTCFF - MBOT
32%
Poorly correlated
+7.66%
POAI - MBOT
31%
Poorly correlated
+6.67%
BNGO - MBOT
31%
Poorly correlated
+2.50%
More